ORKA — Oruka Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Arca Biopharma Announces 1-For-12 Reverse Stock Split In Connection With The Proposed Merger With Oruka Therapeutics
Brief: Arca Biopharma Declares Special Dividend In Connection With Proposed Oruka Therapeutics Merger
Brief: Adage Capital Management Reports 8.28% Stake In Arca Biopharma - SEC Filing
U.S. STOCKS ON THE MOVE-Identiv, Levi Strauss, cannabis firms
U.S. STOCKS ON THE MOVE-Spotify, Ulta Beauty, SPAR Group
ARCA Biopharma surges on deal to merge with Oruka Therapeutics
ARCA Biopharma jumps on deal to merge with Oruka Therapeutics
Brief: ARCA biopharma Inc Says At Effective Time Of First Merger, Board Is Expected To Consist Of Five Members
Brief: ARCA Biopharma And Oruka Therapeutics Announce Merger Agreement
Brief: ARCA biopharma Q3 EPS USD -0.1
Brief: ARCA biopharma, Inc. Q2 net income USD -1.5 million
Brief: ARCA Biopharma Announces Second Quarter 2023 Financial Results
Brief: Arca Biopharma Announces 2022 Financial Results
Brief: James Flynn Joins Arca Biopharma Board Of Directors
Brief: Arca Biopharma Announces Third Quarter 2022 Financial Results
Brief: ARCA Biopharma Announces Q2 2022 Financial Results
Brief: Arca Biopharma Inc - Jacob Ma-Weaver Has Joined Its Board Of Directors
Brief: ARCA Biopharma Retains Ladenburg Thalmann To Support Strategic Options Review
Brief: Arca Biopharma Announces First Quarter 2022 Financial Results